ClinVar Miner

Submissions for variant NM_001367624.2(ZNF469):c.1663G>A (p.Asp555Asn)

gnomAD frequency: 0.00006  dbSNP: rs749179728
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000328233 SCV000399277 uncertain significance Brittle cornea syndrome 1 2016-06-14 criteria provided, single submitter clinical testing
GeneDx RCV000418901 SCV000535587 uncertain significance not specified 2017-01-04 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the ZNF469 gene. The D555N variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The D555N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position where amino acids with similar properties to Aspartic acid are tolerated across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Additionally, although D555N was not observed in approximately 1,900 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project (average read depth 3X), it was observed in 2/422 (0.47%) alleles from individuals of East Asian ancestry in the Exome Aggregation Consortium (ExAC).Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV002056513 SCV002461311 likely benign not provided 2024-01-29 criteria provided, single submitter clinical testing
Ambry Genetics RCV002402037 SCV002708402 benign Cardiovascular phenotype 2021-05-20 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.